Revvity (MEX:PKI) ROE % Adjusted to Book Value: 1.59% (As of Mar. 2026)


MEX:PKI Revvity Inc MEX:PKI
72 GF Score
Price MXN1,644.85
GF Value MXN1,782.11
! 11 Warning Signs
View Full Analysis

What is Revvity ROE % Adjusted to Book Value?

Revvity MEX:PKI 72 ROE % Adjusted to Book Value is 1.59% as of Mar. 2026. GuruFocus rates MEX:PKI with a GF Score™ of 72/100 and a GF Value™ of MXN1,782.11. The stock has 11 warning signs investors should review.

Revvity's ROE % for the quarter that ended in Mar. 2026 was 2.26%. Revvity's PB Ratio for the quarter that ended in Mar. 2026 was 1.42. Revvity's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was 1.59%.


Revvity ROE % Adjusted to Book Value Related Terms


Revvity ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Revvity's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Revvity ROE % Adjusted to Book Value Chart

Revvity Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.28 2.95 3.79 2.10 1.99

Revvity Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.18 1.37 1.76 3.55 1.59

MEX:PKI vs ICLR, CRL, MEDP: ROE % Adjusted to Book Value Comparison

For the Diagnostics & Research subindustry, Revvity's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Revvity ROE % Adjusted to Book Value vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Revvity's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Revvity's ROE % Adjusted to Book Value falls into.


MEX:PKI
72GF Score
Revvity Inc MEX:PKI
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Revvity ROE % Adjusted to Book Value Calculation

Revvity's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=2.99% / 1.50
=1.99%

Revvity's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=2.26% / 1.42
=1.59%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 1.59% mean?
Revvity (MEX:PKI) has a ROE % Adjusted to Book Value of 1.59% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Revvity and its competitors.
Is Revvity's ROE % Adjusted to Book Value too high?
Revvity's current ROE % Adjusted to Book Value is 1.59%. Overall, Revvity has a GF Score™ of 72/100, reflecting its overall financial health beyond just this single metric.
How does Revvity's ROE % Adjusted to Book Value compare to ICLR and CRL?
Revvity's ROE % Adjusted to Book Value of 1.59% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Diagnostics & Research company?
A good ROE % Adjusted to Book Value depends on the Medical Diagnostics & Research industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Revvity and its competitors. Revvity's current ROE % Adjusted to Book Value is 1.59%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Revvity stock overvalued right now?
Revvity (MEX:PKI) has a current ROE % Adjusted to Book Value of 1.59%. The stock's GF Value™ is MXN1,782.11, compared to a current price of MXN1,644.85 — trading 7.7% below its estimated fair value. The current ROE % Adjusted to Book Value is 1.59%. Revvity's overall GF Score™ is 72/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Revvity (MEX:PKI), the current ROE % Adjusted to Book Value is 1.59% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Revvity (MEX:PKI) Overvalued in 2026?

Based on GuruFocus' analysis, Revvity stock appears to be undervalued. The current stock price of MXN1,644.85 is trading 7.7% below its estimated GF Value™ of MXN1,782.11.

Key valuation signals for MEX:PKI:

  • ROE % Adjusted to Book Value: 1.59%
  • GF Value™: MXN1,782.11 vs. price of MXN1,644.85 (7.7% below fair value)
  • GF Score™: 72/100 with 11 warning signs

No single metric tells the full story. See the MEX:PKI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Revvity Business Description

Address 77 4th Avenue, Waltham, MA, USA, 02451
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
72GF Score

Get the complete analysis for MEX:PKI

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,644.85
Price
MXN1,782.11
GF Value